Published online Jan 14, 2016. doi: 10.3748/wjg.v22.i2.801
Peer-review started: June 2, 2015
First decision: July 14, 2015
Revised: September 1, 2015
Accepted: November 30, 2015
Article in press: December 1, 2015
Published online: January 14, 2016
Processing time: 222 Days and 16.3 Hours
Noncoding RNAs (ncRNAs) represent a class of RNA molecules that typically do not code for proteins. Emerging data suggest that ncRNAs play an important role in several physiological and pathological conditions such as cancer. The best-characterized ncRNAs are the microRNAs (miRNAs), which are short, approximately 22-nucleotide sequences of RNA of approximately 22-nucleotide in length that regulate gene expression at the posttranscriptional level, through transcript degradation or translational repression. MiRNAs can function as master gene regulators, impacting a variety of cellular pathways important to normal cellular functions as well as cancer development and progression. In addition to miRNAs, long ncRNAs, which are transcripts longer than 200 nucleotides, have recently emerged as novel drivers of tumorigenesis. However, the molecular mechanisms of their regulation and function, and the significance of other ncRNAs such as piwi-interacting RNAs in pancreas carcinogenesis are largely unknown. This review summarizes the growing body of evidence supporting the vital roles of ncRNAs in pancreatic cancer, focusing on their dysregulation through both genetic and epigenetic mechanisms, and highlighting the promise of ncRNAs in diagnostic and therapeutic applications of pancreatic cancer.
Core tip: Emerging data suggest that noncoding RNAs (ncRNAs) play a vital role in pancreatic cancer. They contribute to pancreatic cancer through regulation of gene expression at the chromatin, transcriptional, or posttranscriptional level. However, their function and mechanism in pancreatic cancer development are not fully understood. This review focuses on ncRNAs dysregulation in pancreatic cancer through both genetic and epigenetic mechanisms, and the impact of this dysregulation on pancreatic cancer risk. We highlight the potential role of the most promising ncRNAs in diagnostic and therapeutic applications.